SHK promotes PD-L1 degradation and suppresses the immune escape of pancreatic cancer cells by inhibiting the NF-κB/STAT3 and NF-κB/CSN5 signaling pathways [28]. The gene discussed is STAT3; the disease is familial pancreatic carcinoma.